Showing results (121-130 of 132) with videos related to

Sort By:
Pageof 14
Heart and Vessels|April 25, 2012
Differences in hemodynamic responses between intravenous carperitide and nicorandil in patients with acute heart failure syndromesHidetoshi Hattori, Yuichiro Minami, Masayuki Mizuno, et al.
Journal of Arrhythmia|August 3, 2017
Paroxysmal atrial fibrillation recurrences and quality of life in symptomatic patients: A crossover study of flecainide and pilsicainideTsuyoshi Shiga, Koichiro Yoshioka, Eiichi Watanabe, et al.
International Journal of Palliative Nursing|November 23, 2019
Development and validation of support tools for advance care planning in patients with chronic heart failureYasuko Takada, Yasuhiro Hamatani, Yukie Kawano, et al.
Heart and Vessels|September 11, 2025
Prognostic significance of right ventricular-pulmonary artery coupling assessed by TAPSE/PASP ratio in patients with HFmrEFManami Ono, Yurika Fukunaga, Atsushi Suzuki, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|January 28, 2020
Development and Practical Test of Quality Indicators for Palliative Care in Patients With Chronic Heart FailureYasuhiro Hamatani, Yasuko Takada, Yoshihiro Miyamoto, et al.
ESC Heart Failure|March 5, 2019
Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in JapanTsuyoshi Shiga, Atsushi Suzuki, Shoji Haruta, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|March 10, 2015
The Speckle Tracking Imaging for the Assessment of Cardiac Resynchronization Therapy (START) studyTakeshi Maruo, Yoshihiro Seo, Satoshi Yamada, et al.
Scientific Reports|February 2, 2018
Genetic basis of cardiomyopathy and the genotypes involved in prognosis and left ventricular reverse remodelingTakashige Tobita, Seitaro Nomura, Takanori Fujita, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 16, 2018
Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysisHiroki Maruyama, Kaori Miyata, Mariko Mikame, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 14, 2018
Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysisHiroki Maruyama, Kaori Miyata, Mariko Mikame, et al.
Pageof 14